Cover Image

Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults.

BACKGROUND:The bivalent whole-cell (BivWC) oral cholera vaccine (Shanchol) is effective in preventing cholera. However, evaluations of immune responses following vaccination with BivWC have been limited. To determine whether BivWC induces significant mucosal immune responses, we measured V. cholerae...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wilfredo R Matias (Author), Brie Falkard (Author), Richelle C Charles (Author), Leslie M Mayo-Smith (Author), Jessica E Teng (Author), Peng Xu (Author), Pavol Kováč (Author), Edward T Ryan (Author), Firdausi Qadri (Author), Molly F Franke (Author), Louise C Ivers (Author), Jason B Harris (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2016-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
by: Brie Falkard, et al.
Published: (2019)

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
by: Richelle C Charles, et al.
Published: (2014)

Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study
by: Molly F Franke, ScD, et al.
Published: (2018)

Food insecurity and self-reported cholera in Haitian households: An analysis of the 2012 Demographic and Health Survey.
by: Aaron Richterman, et al.
Published: (2019)

Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
by: Omowunmi Aibana, et al.
Published: (2013)

Correction: Cholera Vaccination Campaign Contributes to Improved Knowledge Regarding Cholera and Improved Practice Relevant to Waterborne Disease in Rural Haiti.
by: Omowunmi Aibana, et al.
Published: (2013)

Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.
by: Fahima Chowdhury, et al.
Published: (2020)

Safety of oral cholera vaccines during pregnancy in developing countries
by: Ashraful Islam Khan, et al.
Published: (2017)

Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.
by: Mohammad Murshid Alam, et al.
Published: (2014)

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines
by: Maria Rosario Z. Capeding, et al.
Published: (2017)

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
by: Kamrul Islam, et al.
Published: (2018)

Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
by: Aklima Akter, et al.
Published: (2019)

Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
by: Justin Im, et al.
Published: (2019)

Vaccines plus water, sanitation, and hygiene interventions in the fight against cholera - Authors' reply
by: Louise C Ivers
Published: (2017)

Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh
by: Ashraful Islam Khan, et al.
Published: (2019)

Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial
by: Lina Cordero De Los Santos, et al.
Published: (2018)

A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
by: Md Abu Sayeed, et al.
Published: (2015)

Improving immunization approaches to cholera
by: Amit Saha, et al.
Published: (2017)

Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals
by: Xiao-Juan Yu, et al.
Published: (2020)

Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis
by: Dr. Louise C Ivers, MBBCh, et al.
Published: (2015)

Using Mobile Health (mHealth) and geospatial mapping technology in a mass campaign for reactive oral cholera vaccination in rural Haiti.
by: Jessica E Teng, et al.
Published: (2014)

Deciphering the possible role of ctxB7 allele on higher production of cholera toxin by Haitian variant Vibrio cholerae O1.
by: Arindam Naha, et al.
Published: (2020)

Barriers to HPV Vaccination Among Unvaccinated, Haitian American College Women
by: Dudith Pierre-Victor, et al.
Published: (2018)

Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand
by: Karan Thakkar, et al.
Published: (2023)

Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia
by: Karan Thakkar, et al.
Published: (2023)

The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
by: Ashraful Islam Khan, et al.
Published: (2018)

Cholera Infection Risks and Cholera Vaccine Safety in Pregnancy
by: Pamela El Hayek, et al.
Published: (2023)

New strategies for cholera control
by: Louise C Ivers
Published: (2016)

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
by: Li-Wei Shi, et al.
Published: (2023)

An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.
by: Suman Kanungo, et al.
Published: (2015)

Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools.
by: Md Abu Sayeed, et al.
Published: (2018)

Stockpiling oral cholera vaccine
by: Stephen Martin, et al.
Published: (2012)

Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh
by: Iqbal Ansary Khan, et al.
Published: (2019)

The reactive cholera vaccination campaign in urban Dhaka in 2022: experience, lessons learned and future directions
by: Zahid Hasan Khan, et al.
Published: (2024)

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children.
by: Muhammad Ikhtear Uddin, et al.
Published: (2016)

Factors associated with diarrheal disease among children aged 1-5 years in a cholera epidemic in rural Haiti
by: Hilary A. Dolstad, et al.
Published: (2021)

Factors associated with diarrheal disease among children aged 1-5 years in a cholera epidemic in rural Haiti.
by: Hilary A Dolstad, et al.
Published: (2021)

High hopes for oral cholera vaccine
Published: (2010)

Effectiveness of oral cholera vaccine in Haiti
by: Francisco J Luquero, et al.
Published: (2015)

The case for ring vaccinations with special consideration of oral cholera vaccines
by: Jacqueline Deen, et al.
Published: (2018)